SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

CCI gives green signal for Nirma’s acquisition in Glenmark Life Sciences

20 Dec 2023 Evaluate

The Competition Commission of India (CCI) has given approval for Nirma’s acquisition of majority shareholding in Glenmark Life Sciences. In September this year, Glenmark Pharmaceuticals’ board had approved to divest 75 per cent stake in its subsidiary Glenmark Life Sciences to Nirma for Rs 5,651.5 crore.

Ahmedabad-based Nirma is known for its detergents, soap, and dishwashing bars. It is also into the manufacturing of industrial products like soda ash, linear alkyl benzene, alfa olefin sulphonates, fatty acid, glycerine, and sulphuric acid. 

Glenmark Life Sciences is in the business of making high-quality drugs by unlocking the possibilities of science.


Alivus Life Sciences Share Price

1065.95 -0.70 (-0.07%)
20-Apr-2026 15:28 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1666.00
Dr. Reddys Lab 1226.10
Cipla 1228.55
Zydus Lifesciences 932.60
Lupin 2326.80
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×